Oppenheimer Upgrades Oracle to Outperform

Analyst: Brian Schwartz 1 min read Reproduced verbatim
Rating
Outperform
Upgraded
Target
$185
Outcome
Reached
on April 22, 2026

Oppenheimer’s latest target on Oracle is now $275 (Oct 29, 2026); the median of 23 firms is $240. Oppenheimer has reached 76% of its year-old targets (29 scored).

Oppenheimer and Oracle logos

What the analyst said

Oppenheimer analyst Brian Schwartz upgraded Oracle (NYSE: ORCL) from Perform to Outperform with a price target of $185.00.

“We upgrade ORCL to Outperform from Perform and initiate a $185 PT. While our call may be early, since it will take time for Oracle to show financial success as a more capital-intensive business in future results, we see a favorable risk/reward after the stock’s multiples have been cut by more than half since September.

Our rating upgrade is premised on the following: 1) Strong EPS compounder. Our base case haircuts management’s revenue guidance by 25% and EPS still doubles by FY30E. 2) Mitigating risks. Counterparty, financing, and execution risks are starting to mitigate from ORCL’s recent capital raise and megacustomer announcements (OpenAI, TikTok).

3) AI winner. Despite negative SaaS sentiment overhanging valuation, Oracle is relatively immune from AI disruption. 4) Sentiment shift. ORCL is broadly underowned by institutional investors.”

Cite this note: Price Target, "Oppenheimer Upgrades Oracle to Outperform," February 25, 2026. https://price-target.com/2026/02/25/170212/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $101. The 23 analysts who set a target in the last 3 months range from $155 to $400, with a median of $240. This $185 target is 23% below the median.

Since the note ORCL has moved −31% (from $146). 12-month window: day 268 of 365, closes on February 25, 2027.

Track record

This call✓ Target reached on April 22, 2026, 2 months after the note.

Firm track recordOppenheimer: 76% of its 29 targets at least a year old were reached within 12 months (#18 of 29 firms). Accuracy ranking →

Oppenheimer on Oracle

Oppenheimer price targets on Oracle

7 calls from February 25, 2026 to October 29, 2026. The target went from $185 to $275 (+49%). The rating stayed Buy.

Oppenheimer targetORCL share price
  1. October 29, 2026Kept the $275 targetBuy$275
  2. September 11, 2026Kept the $275 targetBuy$275
  3. June 11, 2026Kept the $275 targetBuy$275
  4. June 8, 2026Target raised from $235 (+17%)Buy$275
  5. May 12, 2026Target raised from $210 (+12%)Buy$235
  6. March 11, 2026Target raised from $185 (+14%)Buy$210
  7. February 25, 2026 This noteEarliest call shownBuy$185
Share Reddit StockTwits
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.